Status:
UNKNOWN
Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery
Lead Sponsor:
Centro Cardiologico Monzino
Collaborating Sponsors:
Catholic University, Italy
University of Chieti
Conditions:
Coronary Arteriosclerosis
Eligibility:
All Genders
55-80 years
Phase:
PHASE2
Brief Summary
This study is a randomized open label study that implies the administration of asprin according to three different regimens. The aims of the study are: * to establish whether coronary artery bypass ...
Eligibility Criteria
Inclusion
- informed consent of the study signed
- coronary artery bypass graft and / or aortic valve replacement surgery with bioprostheses
- age between 55 and 80
- ejection fraction \> 30%.
Exclusion
- excessive bleeding (\> 1000mL / 6 h) or the need of re operation for bleeding
- perioperative myocardial infarction
- stroke or renal failure requiring dialysis and need waiting for post-operative anticoagulation
- patients undergoing coronary artery bypass grafting procedure as a consequence of failed percutaneous coronary intervention
- patients undergoing off-pump coronary artery bypass graft
- overt kidney or liver disease
- therapies that influence the coagulation
- fertile women
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT01466452
Start Date
September 1 2011
End Date
September 1 2013
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cardiologico Monzino, IRCCS
Milan, Milano, Italy, 20138